Orthofix International (OFIX) Tops Q2 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- CoreWeave stock drops on dilution fears and debt concerns
Orthofix Reports Second Quarter 2021 Results
August 6, 2021 7:00 AM EDTNet sales of $121 million, up 66% compared to prior year and 5% compared to the second quarter of 2019 U.S. Spinal Implants net sales grew 56% compared to prior year and 37% over the second quarter of 2019 Strong performance from our U.S. M6-C artificial cervical disc and FITBONE® limb lengthening system with approximately $9 million in combined sales Company raises full year 2021 revenue and adjusted EBITDA guidance
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported its financial... More



